Effectiveness of subcutaneous tocilizumab in refractory adult Still’s disease: report of three cases and a review of the literature-Reference-Cited by-同舟云学术

Effectiveness of subcutaneous tocilizumab in refractory adult Still’s disease: report of three cases and a review of the literature

Published:2021-04-03 Issue:2 Volume:5 Page:365-370
ISSN:2472-5625
Container-title:Modern Rheumatology Case Reports
language:en
Short-container-title:Modern Rheumatology Case Reports

Author:

Torigoe Masataka¹²,Maeshima Keisuke¹,Kuriyama Yuhei¹,Abe Itomi¹,Ozaki Takashi¹,Omura Yuichi¹,Umeki Tatsuhito¹,Imada Chiharu³,Ishii Koji³,Shibata Hirotaka¹

Affiliation:

1. Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Yufu City, Oita, Japan

2. Department of Rheumatology, National Hospital Organization, Beppu Medical Center, Beppu City, Oita, Japan

3. Department of Rheumatology, Oita Red Cross Hospital, Oita City, Oita, Japan

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/24725625.2021.1886402

Reference24 articles.

1. Mechanisms, biomarkers and targets for adult-onset Still’s disease

2. Evidence-based clinical practice guideline for adult Still’s disease

3. A comprehensive review on adult onset Still's disease

4. Cellular and Oxidative Mechanisms Associated with Interleukin-6 Signaling in the Vasculature

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adult-Onset Still’s Disease—A Complex Disease, a Challenging Treatment;International Journal of Molecular Sciences;2022-10-24

2. Interleukin-6 inhibition: a therapeutic strategy for the management of adult-onset Still’s disease;Expert Opinion on Biological Therapy;2021-06-24